We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Experts Ask FDA to Rethink Clinical Trial Exclusion Criteria
Experts Ask FDA to Rethink Clinical Trial Exclusion Criteria
A panel of experts is urging the FDA to reconsider rigid rules excluding certain groups from clinical trials — or at least make decisions on a case-by-case basis.